Latest & greatest articles for corticosteroids

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on corticosteroids or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on corticosteroids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for corticosteroids

1. Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma

Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma Comparative Effectiveness Review Number 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma e Comparative Effectiveness Review Number 194 Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 (...) Questions (KQs) 1c and 2a-c. These KQs were related to the combined use of inhaled corticosteroids and long-acting beta agonists as controller and quick relief therapy and to the use of long-acting muscarinic antagonists as add-on therapy to inhaled corticosteroids. The original search was conducted in August 2016 using the earliest date for each database. This update was made on November 28, 2017. No new studies met inclusion criteria. iii Key Messages Purpose of Review To assess the efficacy

2018 Effective Health Care Program (AHRQ)

2. Are corticosteroids are useful in bacterial meningitis.

Are corticosteroids are useful in bacterial meningitis. Q&A - corticosteroids for bacterial meningitis - Trip Database NEW! Google+ Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button (...) . An example search might look like (#1 or #2) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Asked 20 Nov 2019 , , corticosteroids for bacterial meningitis Please log in to post a reply Your response: Submit my answer 1 answer Notes about answers If you see something you feel is wrong, don’t criticise (that misses the point of Triple) courteously and supportively give a counter answer. Answers given should be in good faith, but they should

2019 Trip Community Q&A

3. Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? Full Text available with Trip Pro

Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? - Annals of Emergency Medicine Email/Username: Password: Remember me Search Terms Search within Search Share this page Access provided by Volume 74, Issue 1, Pages e1–e3 Are Corticosteroids Beneficial in the Treatment of Community-Acquired Pneumonia? x Thomas Seagraves , MD (EBEM Commentator) , x Michael Gottlieb , MD (EBEM Commentator (...) ) Department of Emergency Medicine, Rush University Medical Center, Chicago, IL DOI: | Publication History Published online: June 21, 2018 Expand all Collapse all Article Outline Take-Home Message For adult patients with severe community-acquired pneumonia, corticosteroids reduce morbidity and mortality. For pediatric patients and adults with nonsevere community-acquired pneumonia, corticosteroids appear to reduce morbidity, but not mortality. Methods Data Sources The authors searched the Cochrane Acute

2019 Annals of Emergency Medicine Systematic Review Snapshots

4. Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19

Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Inhaled corticosteroids: A rapid review of the evidence for treatment or prevention of COVID-19 June 22, 2020 Laura C Armitage and Rachel Brettell On behalf (...) of the Oxford COVID-19 Evidence Service Team Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford Correspondence to: VERDICT This review aimed to synthesise the current literature on the role of inhaled corticosteroids in moderating the disease course or severity of COVID-19 disease. Inhaled ciclesonide has been shown to suppress SARS-CoV-2 replication in cultured cells and it is suggested that it exhibits direct acting anti-viral activity in addition

2020 Oxford COVID-19 Evidence Service

5. Corticosteroids for treatment of sore throat Full Text available with Trip Pro

Corticosteroids for treatment of sore throat Corticosteroids for sore throat: a clinical practice guideline | The BMJ Intended for healthcare professionals Username * Password * Edition: Search form Search Search Corticosteroids for... Corticosteroids for sore throat: a clinical practice guideline CC BY NC Open access (Published 20 September 2017) Cite this as: BMJ 2017;358:j4090 Population This recommendation applies to almost all patients with sore throat: People with sore throat Children (...) of oral Dexamethasone (or equivalent dose of alternative corticosteroid) + standard care 10mg Adults: Children: Standard care Analgesics Antibiotics 0.6mg per kg + + / - + Standard care Analgesics Antibiotics + + / - Recommendation Favours steroids Favours no steroids We suggest short course steroids. Discuss with patients in shared decision making. All Applies to Click for details  Strong Benefits outweigh harms for almost everyone. All or nearly all informed patients would likely want this option

2017 BMJ Rapid Recommendations

6. Corticosteroids

the Cochrane Central Register of Controlled Trials (CENTRAL) which contains the Cochrane ARI Group's Specialised Register, MEDLINE (Ovid), Embase (Elsevier), CINAHL (EBSCO), Web of Science (Thomson Reuters), and LILACS (BIREME) for published studies 2018 8. Corticosteroids - inhaled Corticosteroids - inhaled - NICE CKS Clinical Knowledge Summaries Share Corticosteroids - inhaled - Summary Corticosteroids are synthetic analogues of hormones produced by the adrenal cortex. Inhaled corticosteroids (...) of one day earlier. Reduced need for artificial breathing support was the main benefit for people with non-severe pneumonia. The review showed that using corticosteroids increased levels of blood sugar. This and other potential adverse events were not well 2018 12. Corticosteroids - oral Corticosteroids - oral - NICE CKS Clinical Knowledge Summaries Share Corticosteroids - oral - Summary Corticosteroids are synthetic analogues of hormones produced by the adrenal cortex. Corticosteroids are either

2018 Trip Latest and Greatest

7. COVID-19: Corticosteroids for hospitalized patients

COVID-19: Corticosteroids for hospitalized patients COVID-19: SYSTEMIC CORTICOSTEROIDS FOR HOSPITALIZED PATIENTS A Rapid Guidance Summary from the Penn Medicine Center for Evidence-based Practice Last updated July 27, 2020. All links rechecked July 27 unless otherwise noted. This Rapid Guidance Summary is a description of existing guidance and evidence reviews from a variety of sources that was in effect at the time of publication. It should not be used or interpreted as a clinical practice (...) guideline, but instead can be used in development of local recommendations and policies. Key questions answered in this summary • How should corticosteroid drugs be used in patients with severe COVID-19 disease? Management of patients who are taking corticosteroids for chronic conditions, use of inhaled corticosteroids, and treatment of patients who are pregnant is outside the scope of this report. Summary of major recommendations • Most recent clinical practice guidelines are now consistently

2020 Centre for Evidence-Based Practice, Penn Medicine

8. Treating tennis elbow (lateral epicondylalgia) with corticosteroid injections are beneficial in the short term but harmful in the long term

Treating tennis elbow (lateral epicondylalgia) with corticosteroid injections are beneficial in the short term but harmful in the long term 1 sbu – swedish council on health technology assessment What is tennis elbow? Tendon pain is referred to as tendinopathy when the pain is associated with a tendon, or enthesopathy when the pain is associated with the areas where liga- ments or tendons are attached to the bone. Tendons and their associated tissues can become painful and swollen in response (...) with local injec- tions of the anti-inflammatory agent corticosteroid. Treatment in Sweden Tennis elbow occurs in 0.3–1.1 percent of the Swedish population [1], meaning that between 29,000 and 105,000 Swedish people suffer from tennis elbow each year [2]. Tennis elbow most commonly effects people between the ages of 40 and 60. It is unclear to what extent corticosteroid injections are used to treat tennis elbow in Sweden, however direct communication with several health clinics revealed that the method

2014 Swedish Council on Technology Assessement

9. Do Corticosteroids Benefit Patients With Sore Throat?

Do Corticosteroids Benefit Patients With Sore Throat? Systematic Review Snapshot TAKE-HOME MESSAGE The use of corticosteroids decreases pain and time to symptom resolution in patients with sore throat, especially among those with severe exudative pharyngitis. Do Corticosteroids Bene?t Patients With Sore Throat? EBEM Commentators Julie L. Welch, MD Dylan D. Cooper, MD Department of Emergency Medicine Indiana University School of Medicine Indianapolis, IN Results The literature search identi?ed (...) - ferenceinpatientoutcomesreported. The only possible subgroup compari- son was route of administration, Corticosteroids versus placebo in patients with pharyngitis. Corticosteroid vs Placebo Outcome (95% CI) NNT (95% CI) Number of Studies (Patients) Resolution of pain at 24 h RR¼3.2 (2.0 to 5.1) 3.7 (2.8 to 5.9) 4 (286) Resolution of pain at 48 h RR¼1.7 (1.3 to 2.1) 3.3 (2.4 to 5.6) 3 (209) Time to pain relief MD¼–6.3 h (–9.3 to –3.4) n/a 6 (609) Time to resolution of pain MD¼–14.4 h (–24.0 to –3.9) n/a 5 (500) Recurrence

2013 Annals of Emergency Medicine Systematic Review Snapshots

10. Should HIV-uninfected patients with Pneumocystis pneumonia be treated with corticosteroids?

Should HIV-uninfected patients with Pneumocystis pneumonia be treated with corticosteroids? Chiefs’ Inquiry Corner – March 17th, 2019 – Clinical Correlations Search Chiefs’ Inquiry Corner – March 17th, 2019 March 18, 2019 3 min read Propofol is a short-acting, intravenous sedative-hypnotic that is metabolized by the liver and excreted in the urine as conjugates of 2,6-diisopropyl-1,4 quinol. The pharmacokinetics of propofol favor its use for the induction/maintenance of anesthesia (...) with HIV have a mortality of 20-50%, higher than in patients with HIV. A recent retrospective study of 323 patients with PCP concluded that the addition of early corticosteroids to anti-Pneumocystis therapy in patients without HIV was not associated with improved respiratory outcomes. Other, older studies have also shown no benefit, or even some evidence of harm in this population. References: Share: | | Sites We Follow: Useful Links: Questions? Comments? Contact us! © New York University. All rights

2019 Clinical Correlations

11. Do Corticosteroids Improve Mortality or Shock Reversal in Patients With Septic Shock? (SRS therapy)

is a potentially deadly con- dition. Primary treatments include sourcecontrol,antimicrobials,and resuscitation with hemodynamic support (intravenous?uids and va- sopressors).Inaddition,thereexist several accepted indications for corticosteroid therapy in patients with sepsis including immunosup- pression and adrenal insuf?- ciency. 8-11 One of the most common steroid regimens used is hydrocortisone at less than 400 Results of included trials. Study Intervention Mean OR for Shock Reversal (95% CI) Mean (...) Do Corticosteroids Improve Mortality or Shock Reversal in Patients With Septic Shock? (SRS therapy) TAKE-HOME MESSAGE No studied corticosteroid regimen is superior to placebo or any other regimen in patient-centered outcomes including mortality; however, hydrocortisone infusion improves shock reversal compared with placebo or methylprednisolone. Do Corticosteroids Improve Mortality or Shock Reversal in Patients With Septic Shock? EBEM Commentators Brit Long, MD Michael D. April, MD, DPhil

2018 Annals of Emergency Medicine Systematic Review Snapshots

12. Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes

and adrenal suppression. Intended Users Maternity care providers including midwives, family physicians, and obstetricians. Target Population Pregnant women. Evidence Medline, PubMed, Embase, and the Cochrane Library were searched from inception to September 2017. Medical Subject Heading (MeSH) terms and key words related to pregnancy, prematurity, corticosteroids, and perinatal and neonatal mortality and morbidity were used. Statements from professional organizations including that of the National (...) Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 9, Pages 1219–1239 No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes x Amanda Skoll , MD * Vancouver, BC x Amélie Boutin , PhD * Québec City, QC x Emmanuel Bujold , MD, MSc Québec City, QC x Jason

2018 Society of Obstetricians and Gynaecologists of Canada

13. Allergic Rhinitis - Guidelines for Prescribing Intranasal Corticosteroids

that INCS are not effective for hormonal rhinitis in pregnancy (nasal congestion without any signs of upper respiratory infection or known allergic cause). If the patient has previously diagnosed allergic rhinitis, treatment with antihistamines and/or intranasal corticosteroids is considered safe. Lactation: Use of nasal corticosteroids while breastfeeding is considered acceptable. Children : Mometasone or fluticasone recommended because systemic absorption is minimal and there is no evidence of growth (...) Allergic Rhinitis - Guidelines for Prescribing Intranasal Corticosteroids Allergic Rhinitis - Guidelines for Prescribing Intranasal Corticosteroids - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Allergic Rhinitis - Guidelines for Prescribing Intranasal Corticosteroids An inflammatory disorder of the nose which occurs when the membranes lining the nose become sensitized to allergens. Mediated by immunoglobulin E (IgE

2017 medSask

14. Antenatal Corticosteroid Therapy for Fetal Maturation

from repeated courses (especially in the reduction and severity of respiratory distress), there also are animal and human data that suggest deleterious effects on the fetus regarding cerebral myelination, lung growth, and function of the hypothalamic–pituitary–adrenal axis. Follow-up of children at 2 years of age who were exposed to repeat courses of antenatal corticosteroids showed no significant difference in physical or neurocognitive measures in two studies ( , ), and the same outcome was found (...) in younger children in a third study ( ). Although not statistically significant, the relative risk of cerebral palsy in infants exposed to serial courses of antenatal corticosteroids (RR, 5.7; 95% confidence interval, 0.7–46.7; P =.12) in one study is of concern and warrants further study (39). Maternal effects include increased risk of infection and suppression of the hypothalamic–pituitary–adrenal axis ( , ). Regularly scheduled repeat courses or serial courses (more than two) are not currently

2017 American College of Obstetricians and Gynecologists

15. The use of systemic corticosteroids for treatment of COVID-19

The use of systemic corticosteroids for treatment of COVID-19 Crticosteroid treatment of COVID-19 in those with & without asthma ') Cookie Notice This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our for more details. OK Menu Search Main navigation Utility navigation / Search navigation Search Search AAAAI Breadcrumb navigation ▸ ▸ The use of systemic corticosteroids for treatment of COVID-19 | The use of systemic corticosteroids (...) for treatment of COVID-19 Q: 3/11/2020 There is some concern about oral corticosteroid consumption in patients with asthma attack due to COVID-19? A: The use of systemic corticosteroids for treatment of COVID-19 lung disease in individuals without asthma is not recommended. There is no data at this time to support not using all standard asthma therapeutic measures, including systemic corticosteroids, in individuals with asthma and a COVID-19 infection. Eric Macy, MD, MS, FAAAAI Utility navigation Support

2020 American Academy of Allergy, Asthma & Immunology - Ask the Expert

16. The efficacy of using intra-articular corticosteroid injections at the first metatarsophalangeal joint to relieve symptomatic osteoarthritis: a critical review of the literature

The efficacy of using intra-articular corticosteroid injections at the first metatarsophalangeal joint to relieve symptomatic osteoarthritis: a critical review of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

17. In adults with lateral hip pain post Total Hip Replacement (THR) (anterior lateral approach), is physiotherapy more effective in reducing pain and improving function than corticosteroid injection?

In adults with lateral hip pain post Total Hip Replacement (THR) (anterior lateral approach), is physiotherapy more effective in reducing pain and improving function than corticosteroid injection? Getting Evidence into Clinical Practice: Musculoskeletal Research Facilitation Group (CAT Group) Date: February 2017 CAT Lead: Tandi Coetzee/Treena Larkin Date CAT completed: February 2017 Date CAT to review: February 2019 Email: Treena.Larkin@nhs.net Specific Question: In adults with lateral hip pain (...) post Total Hip Replacement (THR) (anterior lateral approach), is physiotherapy more effective in reducing pain and improving function than corticosteroid injection? Clinical bottom line Search results produced no studies comparing physiotherapy intervention and corticosteroid injection to improve pain or function in adults with lateral hip pain post THR. Current clinical practice should remain unchanged due to the lack of evidence. Why is this important? Lateral hip pain occurs in 4.4 % of post

2018 Public Health England

18. Antenatal corticosteroid

corticosteroids NFOG Page 36 of 36 Forslag til patientinformation Patientinformation: lungemodnende behandling med binyrebark hormon Hvis du er blevet anbefalet lungemodnende behandling med binyrebark hormon kan du læse denne folder for yderligere information. Børn som bliver født før graviditetsuge 34 har øget risiko for at få vejrtrækningsproblemer når de bliver født og behandling med binyrebarn hormon også kaldet Celeston eller Bethametason hjælper med til at forbedre barnets chancer for undgå denne (...) Antenatal corticosteroid Antenatal corticosteroids NFOG Page 1 of 36 Antenatal corticosteroid DSOG (Danish Society of Obstetrics and Gynecology) Approved on January 2018 by the participants at the yearly obstetric guideline meeting in DSOG Page 1: English summary Page 2-36: The entire guideline in Danish including references BEFORE WEEK 24 0/7 Antenatal corticosteroid* (ACS) may be considered from GA 23 0/7. Consultation with tertiary department is recommended (statement). 1b A WEEK 23 5/7

2018 Nordic Federation of Societies of Obstetrics and Gynecology

19. Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy

Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy Prescrire IN ENGLISH - Spotlight ''Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy'', 1 June 2015 {1} {1} {1} | | > > > Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |    (...) |  Spotlight Epicondylitis (tennis elbow) and corticosteroids: less success than physiotherapy A local corticosteroid injection gives short-term relief, but increases the risk of recurrence, in contrast to physiotherapy. Patients suffering from epicondylitis, or "tennis elbow", generally experience pain around the outside of the elbow. The pain is generally moderate and is triggered by certain movements, but it can become intense and continual, restricting activity and reducing grip strength

2015 Prescrire

20. Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy). Full Text available with Trip Pro

Antiviral Agents Added to Corticosteroids for Early Treatment of Adults With Acute Idiopathic Facial Nerve Paralysis (Bell Palsy). Compared with oral corticosteroids alone, are oral antiviral drugs associated with improved outcomes when combined with oral corticosteroids in patients presenting within 72 hours of the onset of Bell palsy?Compared with oral corticosteroids alone, the addition of acyclovir, valacyclovir, or famcyclovir to oral corticosteroids for treatment of Bell palsy

2016 JAMA